Trial intelligence / Profile preview

Efficacy of a Combined Surgical and Pharmacological Therapy to Treat Mixed Urinary Incontinence

NCT01899794Phase 4Completed

Sponsor
Jewish General Hospital
Start
Oct 2007
Primary completion
Apr 2013
Modality
Small Molecules
01

Overview

A Phase 4 trial of oxybutynin in mixed urinary incontinence (MUI), sponsored by Jewish General Hospital. Started Oct 2007; status: completed.

02

Drugs

oxybutynin
03

Conditions

mixed urinary incontinence (MUI)

Beyond the preview

Go deeper on NCT01899794.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01899794.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call